Research presented at AANP 2025 discusses strategies for reducing maternal mortality, including addressing cardiovascular, hypertensive, and mental health conditions.

When we think of the symptoms of major depressive disorder (MDD) we typically think of persistent feelings of sadness, lack of energy, or difficulty finding the motivation to get out of bed, let alone ...

Selective serotonin reuptake inhibitor (SSRI) or selective norepinephrine reuptake inhibitor (SNRI) leading to sleep agent prescribing. SSRIs and SNRIs are commonly prescribed for depression.

Solriamfetol is a dopamine and norepinephrine reuptake inhibitor (DNRI), TAAR1 agonist, and 5-HT 1A agonist being developed for the treatment of attention deficit hyperactivity disorder (ADHD), major ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...

AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor for the management of fibromyalgia and other conditions. Esreboxetine, the SS-enantiomer of reboxetine, is more ...